Related Experiment Videos

Evaluation of nitric oxide production by Leishmania infantum-infected dog macrophages

M A Panaro1, A Fasanella, S Lisi

  • 1Istituto di Anatomia Umana Normale, Università di Bari, Italy.

Insights

This study investigated how dog macrophages kill Leishmania infantum. Macrophages produced nitric oxide (NO) when stimulated, which aided in parasite killing, but this was inhibited by L-N monomethylarginine (L-NMMA).

Area of Science:

  • Immunology
  • Parasitology
  • Veterinary Medicine

Background:

  • Leishmania (L.) protozoa cause chronic visceral disease in mammals, including dogs.
  • The anti-Leishmania mechanisms of canine macrophages remain poorly understood.
  • Leishmania infantum is a significant pathogen in canine visceral leishmaniasis.

Purpose of the Study:

  • To evaluate the nitric oxide (NO) production and killing capacity of canine macrophages against Leishmania infantum.
  • To investigate the role of NO in the macrophage-mediated killing of Leishmania in dogs.

Main Methods:

  • Macrophage cultures from healthy dogs were infected with Leishmania infantum.
  • Nitric oxide (NO) production was measured via nitrite (NO2) levels.
  • Macrophages were stimulated with Concanavalin A (ConA)-activated PBMC supernatants and Salmonella typhimurium lipopolysaccharide (LPS).
  • Experiments were conducted with and without the NO synthase inhibitor L-N monomethylarginine (L-NMMA).

Main Results:

  • Leishmania infantum-infected macrophages showed significantly higher NO production upon stimulation with ConA-activated PBMC supernatants and LPS compared to controls.
  • NO production was completely abolished in the presence of L-NMMA.
  • Macrophage killing of Leishmania was significantly reduced when L-NMMA was present.

Conclusions:

  • Canine macrophages produce nitric oxide (NO) in response to Leishmania infantum infection and stimulation.
  • NO plays a crucial role in the macrophage-mediated killing of Leishmania in dogs.
  • Targeting NO production could be a potential therapeutic strategy for canine leishmaniasis.

Related Concept Videos